Images can contain key information, highlight abnormalities
The U.S. Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT). Representing the first intelligent assistant of the new AI-Rad Companion platform, AI-Rad Companion Chest CT helps radiologists interpret images of the thorax (chest) quickly with desired accuracy and precision, and automatically documents these findings as structured reports.
Although CT chest images are mainly assessed by radiologists with regard to the primary indication, these images contain additional clinically relevant information. The algorithms in AI-Rad Companion Chest CT were trained on extensive datasets and annotated by qualified clinical specialists to provide segmentation, measurement, and highlighting of key anatomical structures, to support quantitative and qualitative analysis.
Using CT images of the chest, AI-Rad Companion Chest CT differentiates among various structures in that region – including the lungs, heart, and aorta – highlights them individually, and marks and measures potential abnormalities, such as coronary calcifications.
“AI-Rad Companion Chest CT builds on our decades-long expertise in AI and machine learning, digitalizing healthcare and helping providers perform multi-organ image interpretation of the chest with enhanced detection, accuracy, and precision, which can potentially improve outcomes,” said David Pacitti, President and Head of the Americas at Siemens Healthineers.
SOURCE: SIEMENS
